Your browser doesn't support javascript.
A new SYBR Green real-time PCR to detect SARS-CoV-2.
Marinowic, D R; Zanirati, G; Rodrigues, F V F; Grahl, M V C; Alcará, A M; Machado, D C; Da Costa, J C.
  • Marinowic DR; Brain Institute of Rio Grande do Sul (BraIns), Pontifical Catholic University of Rio Grande do Sul, Av Ipiranga, 6690, Building 63, Jardim Botânico, Porto Alegre, Rio Grande do Sul, 90610.000, Brazil.
  • Zanirati G; Graduate Program in Medicine and Health Sciences, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.
  • Rodrigues FVF; Graduate Program in Medicine, Pediatrics and Child Health, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.
  • Grahl MVC; Graduate Program in Biomedical Gerontology, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.
  • Alcará AM; School of Medicine, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.
  • Machado DC; Brain Institute of Rio Grande do Sul (BraIns), Pontifical Catholic University of Rio Grande do Sul, Av Ipiranga, 6690, Building 63, Jardim Botânico, Porto Alegre, Rio Grande do Sul, 90610.000, Brazil.
  • Da Costa JC; Graduate Program in Medicine, Pediatrics and Child Health, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.
Sci Rep ; 11(1): 2224, 2021 01 26.
Article in English | MEDLINE | ID: covidwho-1049969
ABSTRACT
Phylogenetic analysis has demonstrated that the etiologic agent of the 2020 pandemic outbreak is a betacoronavirus named SARS-CoV-2. For public health interventions, a diagnostic test with high sensitivity and specificity is required. The gold standard protocol for diagnosis by the Word Health Organization (WHO) is RT-PCR. To detect low viral loads and perform large-scale screening, a low-cost diagnostic test is necessary. Here, we developed a cost-effective test capable of detecting SARS-CoV-2. We validated an auxiliary protocol for molecular diagnosis with the SYBR Green RT-PCR methodology to successfully screen negative cases of SARS-CoV-2. Our results revealed a set of primers with high specificity and no homology with other viruses from the Coronovideae family or human respiratory tract pathogenic viruses, presenting with complementarity only for rhinoviruses/enteroviruses and Legionella spp. Optimization of the annealing temperature and polymerization time led to a high specificity in the PCR products. We have developed a more affordable and swift methodology for negative SARS-CoV-2 screening. This methodology can be applied on a large scale to soften panic and economic burden through guidance for isolation strategies.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: Organic Chemicals / Real-Time Polymerase Chain Reaction / COVID-19 Nucleic Acid Testing / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Etiology study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Sci Rep Year: 2021 Document Type: Article Affiliation country: S41598-021-81245-0

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Organic Chemicals / Real-Time Polymerase Chain Reaction / COVID-19 Nucleic Acid Testing / SARS-CoV-2 / COVID-19 Type of study: Diagnostic study / Etiology study / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Sci Rep Year: 2021 Document Type: Article Affiliation country: S41598-021-81245-0